With its stock down 5.2% over the past three months, it is easy to disregard Pro Medicus (ASX:PME). But if you pay close attention, you might gather that its strong financials could mean that the ...

Pro Medicus Limited (ASX:PME) shareholders might be concerned after seeing the share price drop 29% in the last quarter. But over five years returns have been remarkably great. To be precise, the ...

Fintel reports that on April 7, 2025, BELL POTTER SECURITIES downgraded their outlook for Pro Medicus (ASX:PME) from Buy to Hold. As of April 2, 2025, the average one-year price target for Pro Medicus ...

ASX company news and announcements for Pro Medicus Limited (PME) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Pro Medicus Limited ...

Pro Medicus Ltd. Annual stock financials by MarketWatch. View the latest PME financial statements, income statements and financial ratios.

The average one-year price target for Pro Medicus (ASX:PME) has been revised to $226.59 / share. This is a decrease of 28.61% from the prior estimate of $317.39 dated February 1, 2026. The price ...

The latest announcement is out from Pro Medicus Limited ( (AU:PME)). Pro Medicus director Anthony Barry Hall has marginally increased his stake in the healthcare imaging software group through an ...

The latest update is out from Pro Medicus Limited ( (AU:PME)). Pro Medicus Limited has disclosed a minor change in the shareholding of Director Sam Aaron Hupert, who has increased his direct interest ...

FPH.AXFisher & Paykel Healthcare Corporation LimitedA$33.31+0.36% ...